Search research articles
Contact Us
Filters
Showing results (231-240 of 265) with videos related to
Page
of 27
Sort By:
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
January 9, 2009
Heritable pathologic cardiac hypertrophy in adulthood is preceded by neonatal cardiac growth restriction
Enzo R Porrello, James R Bell, Jonathan D Schertzer, et al.
Diabetes
|
December 16, 2020
Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis
Arpeeta Sharma, Judy S Y Choi, Nada Stefanovic, et al.
Scientific Reports
|
May 30, 2023
Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities
Arpeeta Sharma, Judy S Y Choi, Anna M D Watson, et al.
Frontiers in Physiology
|
September 20, 2021
Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy
Alex M Parker, Mitchel Tate, Darnel Prakoso, et al.
British Journal of Pharmacology
|
August 18, 2024
Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists
Cheng Peng, Elizabeth A Vecchio, Anh T N Nguyen, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
December 25, 2012
Low intrinsic exercise capacity in rats predisposes to age-dependent cardiac remodeling independent of macrovascular function
Rebecca H Ritchie, Chen Huei Leo, Chengxue Qin, et al.
Journal of Medicinal Chemistry
|
May 1, 2019
Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists
Girdhar Singh Deora, Cheng Xue Qin, Elizabeth A Vecchio, et al.
Cardiovascular Diabetology
|
November 20, 2024
Lipoxin A<sub>4</sub> improves cardiac remodeling and function in diabetes-associated cardiac dysfunction
Ting Fu, Muthukumar Mohan, Madhura Bose, et al.
Cardiovascular Research
|
June 16, 2024
Novel formylpeptide receptor 1/2 agonist limits hypertension-induced cardiovascular damage
Jaideep Singh, Kristy L Jackson, Haoyun Fang, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
July 7, 2026
Sex-Specific Responses in the Early Stages of Diet-Induced Cardiovascular-Kidney-Metabolic Syndrome
Abhipree Sharma, Minh Deo, Kevin Tran, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 265) with videos related to
Sort By:
Page
of 27
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
January 9, 2009
Heritable pathologic cardiac hypertrophy in adulthood is preceded by neonatal cardiac growth restriction
Enzo R Porrello, James R Bell, Jonathan D Schertzer, et al.
Diabetes
|
December 16, 2020
Specific NLRP3 Inhibition Protects Against Diabetes-Associated Atherosclerosis
Arpeeta Sharma, Judy S Y Choi, Nada Stefanovic, et al.
Scientific Reports
|
May 30, 2023
Cardiovascular characterisation of a novel mouse model that combines hypertension and diabetes co-morbidities
Arpeeta Sharma, Judy S Y Choi, Anna M D Watson, et al.
Frontiers in Physiology
|
September 20, 2021
Characterisation of the Myocardial Mitochondria Structural and Functional Phenotype in a Murine Model of Diabetic Cardiomyopathy
Alex M Parker, Mitchel Tate, Darnel Prakoso, et al.
British Journal of Pharmacology
|
August 18, 2024
Biased receptor signalling and intracellular trafficking profiles of structurally distinct formylpeptide receptor 2 agonists
Cheng Peng, Elizabeth A Vecchio, Anh T N Nguyen, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
December 25, 2012
Low intrinsic exercise capacity in rats predisposes to age-dependent cardiac remodeling independent of macrovascular function
Rebecca H Ritchie, Chen Huei Leo, Chengxue Qin, et al.
Journal of Medicinal Chemistry
|
May 1, 2019
Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists
Girdhar Singh Deora, Cheng Xue Qin, Elizabeth A Vecchio, et al.
Cardiovascular Diabetology
|
November 20, 2024
Lipoxin A<sub>4</sub> improves cardiac remodeling and function in diabetes-associated cardiac dysfunction
Ting Fu, Muthukumar Mohan, Madhura Bose, et al.
Cardiovascular Research
|
June 16, 2024
Novel formylpeptide receptor 1/2 agonist limits hypertension-induced cardiovascular damage
Jaideep Singh, Kristy L Jackson, Haoyun Fang, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
July 7, 2026
Sex-Specific Responses in the Early Stages of Diet-Induced Cardiovascular-Kidney-Metabolic Syndrome
Abhipree Sharma, Minh Deo, Kevin Tran, et al.
Page
of 27